MRC et progression
14 essaisFLOW2024Semaglutide and Kidney Outcomes in Type 2 Diabetes with Chronic Kidney DiseaseEMPA-KIDNEY2023Study of Heart and Kidney Protection with EmpagliflozinFIGARO-DKD2021Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney DiseaseDAPA-CKD2020Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney DiseaseFIDELIO-DKD2020Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney DiseaseCREDENCE2019Canagliflozin and Renal Events in Diabetes with Established NephropathySONAR2019Study of Diabetic Nephropathy with AtrasentanSPRINT-CKD2017Systolic Blood Pressure Intervention Trial — chronic kidney disease subgroupVA NEPHRON-D2013Veterans Affairs Nephropathy in DiabetesAASK2002African American Study of Kidney Disease and HypertensionRENAAL2001Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist LosartanIDNT2001Irbesartan Diabetic Nephropathy TrialREIN1997Ramipril Efficacy in NephropathyCaptopril-DN1993Captopril in Diabetic Nephropathy (Collaborative Study Group)